Citation 81267

ASANO,N: KATO,A: MIYAUCHI,M: KIZU,H: KAMEDA,Y: WATSON,A: NASH,RJ: FLEET,GWJ:. (1998). NITROGEN-CONTAINING FURANOSE AND PYRANOSE ANALOGUES FROM HYACINTHUS ORIENTALIS.. 61(5)

Citation Details

TitleNITROGEN-CONTAINING FURANOSE AND PYRANOSE ANALOGUES FROM HYACINTHUS ORIENTALIS.
AuthorsASANO,N: KATO,A: MIYAUCHI,M: KIZU,H: KAMEDA,Y: WATSON,A: NASH,RJ: FLEET,GWJ:
Year1998
Volume61
Issue5

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Hyacinthus orientalis (LILIACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
None
2
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
WEAK ACTIVITY
3
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
WEAK ACTIVITY
4
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
WEAK ACTIVITY
5
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
INACTIVE
6
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
WEAK ACTIVITY
7
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
ACTIVE
8
GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
ACTIVE
9
GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
ACTIVE
10
GLYCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
INACTIVE
11
TREHALASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
WEAK ACTIVITY
12
TREHALASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PYRROLIDINE,3R-4R-DIHYDROXY: 2R-5R--BIS-(HYDROXY-METHYL):
WEAK ACTIVITY
13Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
None
14
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
WEAK ACTIVITY
15
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
WEAK ACTIVITY
16
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
INACTIVE
17
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
WEAK ACTIVITY
18
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
INACTIVE
19
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
ACTIVE
20
GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
ACTIVE
21
GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
ACTIVE
22
GLYCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
INACTIVE
23
TREHALASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
ACTIVE
24
TREHALASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO-D-MANNO:
ACTIVE
25Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
None
26
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
ACTIVE
27
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
ACTIVE
28
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
INACTIVE
29
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
ACTIVE
30
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
ACTIVE
31
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
WEAK ACTIVITY
32
GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
WEAK ACTIVITY
33
GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
WEAK ACTIVITY
34
GLYCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
INACTIVE
35
TREHALASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
INACTIVE
36
TREHALASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-MANNO:
WEAK ACTIVITY
37Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
None
38
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
INACTIVE
39
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
INACTIVE
40
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
INACTIVE
41
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
INACTIVE
42
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
INACTIVE
43
GLUCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
INACTIVE
44
GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
INACTIVE
45
GALACTOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
INACTIVE
46
GLYCOSIDASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
WEAK ACTIVITY
47
TREHALASE INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
INACTIVE
48Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
HEPTIOL,2-5-IMINO-2-5-6-TRIDEOXY-D-GULO:
None
49Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
NOJIRIMYCIN,1-DEOXY:
None
50Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
NOJIRIMYCIN,1-DEOXY-MANNO:
None
51Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
NOJIRIMYCIN,ALPHA-HOMO:
None
52Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
NOJIRIMYCIN,BETA-HOMO:
None
53Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
NOJIRIMYCIN,ALPHA-HOMO-MANNO:
None
54Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
NOJIRIMYCIN,BETA-HOMO-MANNO:
None
55Not specified
ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA
NOJIRIMYCIN,ALPHA-HOMO: 7-O-BETA-D-GLUCOPYRANOSYL:
None
Show SPARQL Queries (1)